AORT 10-Q: SEC filing
Artivion, Inc.
Filed with the SEC on · accession 0001628280-26-071486
AORT filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.
Summary of the filing
Artivion, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures including segment revenue, contingent consideration for the PerClot and Ascyrus Medical acquisitions, and software development costs.
Key details
✦ Ask GOAX AI about this filing — what it means for AORT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AORT?
Click hereFrequently asked questions
What did AORT file with the SEC on Nov 6, 2026?
AORT filed a 10-Q (SEC filing). Artivion, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures including segment revenue, contingent consideration for the PerClot and Ascyrus Medical acquisitions, and software development costs.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other AORT SEC filings
Get alerts when AORT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days